Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/17/2023 | ANNALY CAPITAL MANAGEMENT INC | NLY | Grant | Deferred Stock Units | 8.2k | $0.00 | $0 | | 05/17/2023 |
05/09/2023 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 8.3k | $5.09 | $42.2k | | 05/09/2023 |
09/16/2022 | Larimar Therapeutics, Inc. | ZFGN | Purchase | Common Stock | 317.5k | $3.15 | $1000k | | 09/16/2022 |
05/18/2022 | ANNALY CAPITAL MANAGEMENT INC | NLY | Grant | Deferred Stock Units | 24.4k | $0.00 | $0 | | 05/18/2022 |
05/10/2022 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 8.3k | $2.92 | $24.2k | | 05/10/2022 |
05/19/2021 | ANNALY CAPITAL MANAGEMENT INC | NLY | Grant | Deferred Stock Units | 15.6k | $0.00 | $0 | | 05/19/2021 |
05/12/2021 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (right to buy) | 8.3k | $10.34 | $85.8k | | 05/12/2021 |
05/03/2021 | ANNALY CAPITAL MANAGEMENT INC | NLY | Sale | Common Stock | 80k | $9.18 | $734.4k | 2012 Hamilton Family Trust | 05/03/2021 |
09/29/2020 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (right to buy) | 16.6k | $11.90 | $197.5k | | 09/29/2020 |
06/26/2020 | Larimar Therapeutics, Inc. | ZFGN | Other (acquisition) | Common Stock | 159.4k | $0.00 | $0 | FA Life Sciences, Inc. | 06/26/2020 |
06/26/2020 | Larimar Therapeutics, Inc. | ZFGN | Other (acquisition) | Common Stock | 133.4k | $0.00 | $0 | | 06/26/2020 |
05/20/2020 | ANNALY CAPITAL MANAGEMENT INC | NLY | Grant | Deferred Stock Units | 22.6k | $0.00 | $0 | | 05/20/2020 |
05/15/2020 | ANNALY CAPITAL MANAGEMENT INC | NLY | Purchase | Common Stock | 200k | $5.96 | $1.2M | Cure FA Foundation, Inc. | 05/15/2020 |
05/22/2019 | ANNALY CAPITAL MANAGEMENT INC | NLY | Grant | Deferred Stock Units | 15.6k | $0.00 | $0 | | 05/22/2019 |
05/17/2019 | ANNALY CAPITAL MANAGEMENT INC | NLY | Purchase | Common Stock | 30k | $9.47 | $284.1k | Cure FA Foundation, Inc. | 05/17/2019 |
05/17/2019 | ANNALY CAPITAL MANAGEMENT INC | NLY | Purchase | Common Stock | 30k | $9.47 | $284.1k | | 05/17/2019 |